학술논문

SYNTHETIC RECEPTOR ENABLED DIFFERENTIATION (SHRED), A NOVEL PLATFORM FOR MANUFACTURING OF IPSC-DERIVED CYTOTOXIC INNATE LYMPHOCYTES FOR "OFF-THE-SHELF" CANCER IMMUNOTHERAPIES
Document Type
Journal
Source
JOURNAL FOR IMMUNOTHERAPY OF CANCER; NOV 2022, 10 pA385-pA385, 1p. Supplement: 2
Subject
Language
English
ISSN
20511426